A landmark, way more lenient approach on releasing new crypto projects is now up to the White House for approval.
Continue reading at DailyCoin.
SEC, Paul AtkinsRead More
You might also be interested in reading BioCardia outlines regulatory milestones and targets FDA and PMDA submissions for CardiAMP and Helix in Q4 2025.